Ferret respiratory disease models for the study of lung stem cells

Albert C. Pai, Kalpaj R. Parekh, John F. Engelhardt, Thomas J. Lynch

Source: Eur Respir Monogr 2021; 91: 273-289
Disease area: Airway diseases

Congress or journal article abstractFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Albert C. Pai, Kalpaj R. Parekh, John F. Engelhardt, Thomas J. Lynch. Ferret respiratory disease models for the study of lung stem cells. Eur Respir Monogr 2021; 91: 273-289

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Progress towards human lung regeneration in end-stage respiratory failure: studying human lung development in vitro using organoid cultures of human embryonic lung stem cells
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


Towards human lung regeneration in end-stage respiratory failure: genetically-modifiable 3D organoid culture of human embryonic lung stem cells enables for the first time the study of human lung development in vitro
Source: ERS Lung Science Conference 2018
Year: 2018

Induced pluripotent stem cells for generating lung alveolar epithelial cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 205-221
Year: 2021


Induced pluripotent stem cells for generating lung airway stem cells and modelling respiratory disease
Source: Eur Respir Monogr 2021; 91: 190-204
Year: 2021


Bioengineered models of human lung disease
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


iPSC derived lung stem cells as tools to understand lung regeneration and disease
Source: ERS Lung Science Conference 2021
Year: 2021



Modelling human lung development and disease using pluripotent stem cells
Source: International Congress 2015 – Regenerative medicine of the lung: opportunities and threats
Year: 2015



Intersections of lung progenitor cells, lung disease and lung cancer
Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017
Year: 2017



3D models of human lung development and disease using pluripotent stem cells
Source: International Congress 2019 – From 2D to 3D models of human lung disease: novel developments to rebuild the lung
Year: 2019


The therapeutic potential of the mesenchymal stem cell secretome in a mouse model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Human lung scaffolds to model lung disease and tissue regeneration
Source: International Congress 2018 – Cell-matrix interactions in lung disease and regeneration
Year: 2018


Damage of respiratory epithelial cells in a cell culture model of the graft-versus-host disease
Source: Eur Respir J 2004; 24: Suppl. 48, 107s
Year: 2004

In search of ckit+ stem cells in lung tissue
Source: International Congress 2015 – Cellular and molecular mechanisms of COPD and emphysema
Year: 2015

Characterization of human mesenchymal stem cells phenotype and secretome in a in vitro model of acute lung injury inflammation
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011

Rescue of murine silica-induced lung injury and fibrosis by human embryonic stem cells
Source: Eur Respir J 2012; 39: 446-457
Year: 2012



Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011

Mesenchymal stem cell therapy reduces inflammation and damage in a model of chronic lung disease
Source: ERS Lung Science Conference 2017
Year: 2017

Mesenchymal stem cell therapy in a model of chronic inflammatory lung disease
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019

Characterization of human airway epithelial cell lines as in vitro models of chronic obstructive pulmonary disease
Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery
Year: 2021